Big Pharma Interrupted – their profits are threatened by whole plant based cannabis medicine. The pharmaceutical industry is against legalizing the plant on the basis that it fails to protect the safety of children. If that concern had a miniscule of truth to it, the industry would NOT prescribe their harmful psychotropic drugs to children.
The largest pharmaceutical market in the world is the U.S. – representing 35% of the global market. Those states that have adopted a medical cannabis policy are witnessing a significant drop in prescription drugs including those for pain and for symptoms associated with chemotherapy – two very lucrative money making conditions for Big Pharma).
The pharmaceutical industry is the largest industry raking in massive amounts in revenues at the expense of people suffering from acute health challenges to life threatening diseases. In fact, the Washington Post published specific results for reduced prescriptions including painkillers, anxiety, nausea, psychosis, sleep disorders and depression in those states with a medical marijuana law.
What is the pharmaceutical industry doing about a plant that can reduce their revenues by at least $4 billion annually? This industry is spending an obscene amount of money to discredit this plant as harmful, untested, dangerous and of no use, unless it is of pharmaceutical grade.
Just Say NO to prescription drugs!
When you want to know something about the emerging medical and recreational cannabis industry, where do you turn to for unbiased, current and up to date correct information?
Who owns the online Cannabis News?
Leaf Science has been bought out by ‘a group or web of companies with questionable ethics’ and Leafly was bought out by Privateer Holdings a closely connected corporation to Tilray, one of Canada’s Licensed Producers (LP). Who is Lift.co associated with? My guess is the Tweed – Bedrocan conglomerate.
Why should this matter?
This matters because the information espoused by these so called “newsgroups” are subjectively tainted!
This author has asked each of Canada’s Licensed Producers (LP’s) “Can you supply a full fingerprint of each strain you are selling because the regulated percentage of just THC and CBD is useless …?” To date, NO response has been received by any of the LP’s contacted.
Also, the LP’s in Canada have been stockpiling their inventory (evidence is through Health Canada’s website) which is further evidence that the THC reported in their strains are no longer accurate since THC degrades to CBN within six months.
In reviewing the minutes to a 1971 United Nation ‘symposium’ discussing the research surrounding the chemistry and biological activity of cannabis, the following is an extraction that is noteworthy:
Cannabis research at the Division of Narcotic Drugs, United Nations, Geneva is mandated with the primary function of internationally coordinating cannabis research in order to avoid unnecessary duplication of effort.
The emphasis of this international research was “to elucidate the effects of the compounds responsible for the psychoactive effects of cannabis in man, to quantify the constituents or their metabolites in biological fluids, to determine their toxicity and side effects and to correlate these data with the social effects of the drug.”
At the large number of new and unpublished cannabis research:
The Symposium revealed that a large amount of knowledge had been accumulated on the chemistry of cannabis and the synthesis of the cannabinoids and their metabolites. The report stated that there still remains some uncertainty as to how much THC is absorbed by smoking, to give the biological high. It concluded that THC and cannabis of known potency can be used with confidence in large scale clinical trials. It was determined that within the next few years (by 1975 ?), the clinical data will shed new light on the two basic questions of the UN “How dangerous is cannabis?” and “What should we do about it?”
In other words, the United Nations 1961 Single Convention on Drug Control, vilified this plant without corroborating evidence that supported its placement as a dangerous drug.